In addition, high expression levels of an essential subunit of mTORC2, Rictor, along with overexpression of mTORC2 have been reported in some cancer cells such as glioma cells, whereas miR-153 as an anti-Rictor is downregulated in these cells. The gene discussed is RICTOR; the disease is central nervous system cancer.